Key result
Placental dysregulation in congenital heart disease may affect fetal heart and brain development, contributing to the high rate of neurodevelopmental disorders in this population.
Why the study?
Up to 50% of infants with CHD develop neurodevelopmental disorders, with two-thirds unexplained by postnatal factors, prompting examination of in utero placental, cardiac, and cerebral tissue interactions.
Placental dysregulation may play a key role in the development of neurodevelopmental disorders in infants with congenital heart disease, suggesting placental biomarkers could help identify high-risk infants.
Hypothesis-generating for placental biomarkers in CHD neurodevelopmental risk; prospective validation required before clinical adoption.
Congenital heart disease (CHD) is the primary cause of birth defects, affecting 9 per 1,000 live births. Up to 50% of them will develop neurodevelopmental disorders, two-thirds of which being unexplained by postnatal risk factors. Recent advances suggest a triangular relationship between the placenta and the fetal heart and brain in CHD, consistent with the Developmental Origins of Health and Disease hypothesis, ie, the in utero programming of early and later-in-life noncommunicable cardiometabolic and mental diseases. The current review provides comprehensive evidence of placental, cardiac, and cerebral tissues interactions, and details how placental dysregulation may affect vasculogenesis, angiogenesis and neural tube closure, hemodynamics, energy supply, endocrine function, and epigenetic regulation of the developing heart and brain. Future studies should include placental research, since identifying placental biomarkers would allow early identification of CHD infants at higher risk for neurodevelopmental disorders, leading to targeted preventive personalized interventions.
No takes yet. Share an insight, caveat, or question.
Demonceaux et al. (2025) conducted a review in Congenital heart disease and neurodevelopmental disorders. Placental dysregulation was evaluated. Placental dysregulation in congenital heart disease may affect fetal heart and brain development, contributing to the high rate of neurodevelopmental disorders in this population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: